Metabolic99.2% verified
Move cursor to rotate · 3D render
Metabolic · Compound
Tesamorelin
CAS
218949-48-5
Dose
5mg per vial
Formula
C₂₂₁H₃₆₆N₇₂O₆₇S
MW
5135.85 g/mol
Batch
PX-2026-0154
Purity
99.2%
Stabilized 44-aa GHRH analog. Approved indication in HIV-associated lipodystrophy.
Per vial · CAD
CAD $119
Selected
5mg per vial
Lyophilized · ambient-stable · In stock
Batch PX-2026-0154 →Research use only. Not for diagnostic, therapeutic, or human-consumption use.
Buying in volume? US and UK wholesale handled by direct contact — custom rates by monthly order volume.
Apply to the wholesale program Production COA
Per batch
Verification
3rd party
Form
Lyophilized
Current batch
The chromatogram for this vial.
Batch PX-2026-0154 · HPLC trace
Tesamorelin
Purity
99.2%
Produced
2026-04-24
Verified
2026-04-28
Signed by Independent third-party lab · 2026-04-28Hover the peaks to inspect retention times
Overview
About the compound.
Tesamorelin is a stabilized GHRH(1-44) analog with an N-terminal trans-3-hexenoyl modification. It is the only GHRH analog with regulatory approval — for HIV-associated visceral lipodystrophy — and has been studied in NAFLD and cognitive aging contexts at McGill, the NIH, and a growing European cohort.
Research contexts
GHRH analog researchVisceral adipose biologyNAFLD studies
Batch history
Every batch we’ve ever sent out.
Adjacent research
Compounds that pair with Tesamorelin.
Metabolic99.1% verified
CAS 2381089-83-2
C₂₁₄H₃₃₃N₅₀O₆₅
GLP-3 (Retatrutide)
5mg per vial · Batch PX-2026-0142
From CAD $129
per vial · CAD
Longevity99.0% verified
CAS 53-84-9
C₂₁H₂₇N₇O₁₄P₂
NAD+
500mg per vial · Batch PX-2026-0138
CAD $149
per vial · CAD
Recovery98.9% verified
CAS Blend
BPC-157 · TB-500 · GHK-Cu · KPV
KLOW
50mg blend per vial · Batch PX-2026-0133
CAD $219
per vial · CAD
5mg per vial
CAD $119